|
Market Cap (5-Jul) $117,644,148,736 (6th) |
Close (30-Jun) $277.38 |
Volume (30-Jun) 970,129 |
Shortsold (19-Jun) 1,827,603 (0.38%) (339th) |
|
52w High $308.82 |
52w Low $228.61 |
P/E 32.47 |
EPS 8.29 |
CSL released this announcement to the ASX on 16 November 2020, 9:19. The announcement is not marked as price sensitive, and is 2 page(s) in length and 146.56kb in size.
You can view all announcements from CSL and see how they appear on a price chart on the announcements page.
At the date of this announcement, CSL was 0.247% short sold according to ASIC data. It was ranked the 351st most shorted stock on the ASX. It is now ranked as the 339th most shorted stock on the ASX with 0.377% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from CSL | |
|---|---|
| Market Update | 14 June 2023, 7:56 |
| Notification of cessation of securities - CSL | 8 June 2023, 12:12 |
| Shareholder Briefing | 29 May 2023, 9:26 |
| New Vaccine Manufacturing Facility | 16 November 2020, 9:19 |
| Appendix 2A | 11 November 2020, 9:44 |
| CSLs Annual R&D Investor Briefing 2020 | 20 October 2020, 8:35 |
| Notice of Research & Development Investor Briefing | 19 October 2020, 8:21 |
You must be logged in to post a reply.
CSL 